Road Map

In collaboration with European vaccine stakeholders, the TRANSVAC consortium prepared during its first funding period a roadmap aimed at securing sustainable vaccine development infrastructures in Europe.  Using a bottom-up approach, the needs and priorities regarding European vaccine R&D were identified through a series of stakeholder consultations and workshops, and translated into a proposal for the establishment of a European Vaccine Research & Development Infrastructure (EVRI).

An advanced draft of the roadmap was presented and discussed at the TRANSVAC annual meeting in March 2013, and then circulated for comment and validation amongst European stakeholders.  Overall, the feedback received from the consultation process was very positive.  In addition, a detailed questionnaire circulated during the first round of the consultation process confirmed the proposed activities and services to be of a high priority, as perceived by European vaccine stakeholders.

Finally, the proposal for a European Infrastructure for vaccine R&D was discussed and validated during a workshop held in June 2013, by 70 representatives of vaccine developers and manufacturers (academic researchers, biotech companies, large vaccine development companies, PDPs and other European vaccine-related projects), regulatory authorities, international and national policy makers, and funding agencies.

European vaccine stakeholders present at the workshop were very supportive of the project to establish EVRI as presented in the roadmap, and many expressed interest to join the initiative.  It has been acknowledged that EVRI answers numerous needs of European vaccine developers, has the potential to accelerate the development of new or improved vaccines, and shares the vision of the European research agenda Horizon 2020.

The need for a European vaccine R&D infrastructure has now led to a continuation of the TRANSVAC project for a second funding period under Horizon 2020, with the aim of establishing a long term sustainable European vaccine R&D infrastructure.

Read the TRANSVAC Roadmap 2014

Publication: Roadmap for the establishment of a European vaccine R&D infrastructure, O. Leroy, M. Geels, J. Korejwo, B. Dodet, N. Imbault, S. Jungbluth, Vaccine, 2014

  • What we do

    What we do

  • Who we are

    Who we are

  • Our training courses

    Training courses

  • Latest news

    Latest news